NIBRT and Pfizer announce a new collaboration
The National Institute for Bioprocessing Research and Training (NIBRT) and Pfizer today announced a new collaboration focused on the development and application of advanced process and analytical methods for in-line monitoring and continuous characterisation of bio-pharmaceutical manufacturing processes.
The collaboration, which is funded through Enterprise Ireland’s Innovation Partnership scheme, aims to reduce the requirement for offline analytical testing by integrating automated sampling and analytical characterisation using high resolution liquid chromatography mass spectrometry directly with the bioreactor systems. The system will generate both process and product quality data in near real time, to provide process and analytical scientists with key information to guide development of their bio-pharmaceutical processes.
Read the full press release here